Bausch Health Companies Inc. (BHC)
BHC trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.89
-0.68% on the day
Market cap
$2.2B
Mid cap
Revenue · 2025
$10.3B
+6.7% on 2024
Net income · 2025
$157.0M
1.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BHC on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0000885590 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NJ |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $10.3B |
| Net income | $157.0M |
| Operating income | $1.8B |
| Net margin | 1.5% |
| Operating margin | 17.7% |
| Revenue growth | +6.7% |
| Cash | $1.3B |
| Total assets | $26.4B |
| P/E (computed) | 14.0× |
| P/S (computed) | 0.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2018-03-02 |
| Latest annual report | 10-K | 2026-02-19 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-07-29 |
| Latest proxy | DEFA14A | 2026-04-08 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.2% |
| 1 month | +3.9% |
| 3 months | +19.5% |
| Year to date | -15.3% |
| 1 year | -3.6% |
| From 52-week high | -25.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | $16.36 | -1.15% | $2.2B |
| IRON | Disc Medicine Inc. | $56.60 | -6.42% | $2.2B |
| HRMY | Harmony Biosciences Holdings Inc. | $37.03 | -3.14% | $2.2B |
| PRGO | Perrigo Company plc | $15.37 | -0.52% | $2.1B |
| NRIX | Nurix Therapeutics Inc. | $22.13 | -0.14% | $2.3B |
| PBH | Prestige Consumer Healthcare Inc. | $48.50 | -1.02% | $2.3B |
| PHVS | Pharvaris N.V. | $30.02 | -2.82% | $2.1B |
| IMNM | Immunome Inc. | $17.58 | -8.20% | $2.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier